Beatriz Martin-Antonio

18PUBLICATIONS
112CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 03, 2026
Enhanced antitumoral activity of the academic CAR-T ARI0002h against normal and low BCMA-expressing myeloma cells after incorporating a transmembrane CD28 domain.

Oriol Cardus, Joan Mañé Pujol, Anna de Daniel

|Jul 11, 2025
Microbiota Shape Metabolic and Immune Determinants of CAR-T Therapy and Correlate with Outcomes in Myeloma.

Mireia Uribe-Herranz, Aina Oliver-Caldés, Neus Martínez-Micaelo

|Jun 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited.

Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol

|Dec 18, 2024
Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen.

Esperanza Esquinas, Alvaro Moreno-Sanz, Victor Sandá

|Mar 11, 2024
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.

Aina Oliver-Caldes, Marta Español-Rego, Aintzane Zabaleta

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

Pageof 3

Frequent Collaborators

9 joint publications

Carlos Fernández de Larrea

8 joint publications

Manel Juan

8 joint publications

Aina Oliver-Caldés

6 joint publications

Luis-Gerardo Rodríguez-Lobato